arginine and nimustine

arginine has been researched along with nimustine in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19902 (11.76)18.7374
1990's4 (23.53)18.2507
2000's8 (47.06)29.6817
2010's3 (17.65)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Heuser, K1
Iwasa, H; Kohno, T; Matsutani, M; Satoh, F; Takakura, K; Yamamoto, H1
Akanuma, A; Kohno, T; Maehara, T; Nakamura, O; Sano, K; Sato, F; Shitara, N; Takakura, K; Yamamoto, H1
Dichgans, J; Roth, W; Schmidt, C; Weller, M1
Diete, S; Dietzmann, K; Kirches, E; von Bossanyi, P; Warich-Kirches, M1
Durka, S; Hueber, A; Weller, M1
Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J1
Bamberg, M; Koch, R; Krauseneck, P; Müller, B; Weller, M1
Ernemann, U; Hahn, U; Ritz, R1
Bratengeier, K; Flentje, M; Kölbl, O; Ruprecht, K; Vince, GH; Vordermark, D1
Weller, M1
Flentje, M; Kölbl, O; Rieckmann, P; Roggendorf, W; Ruprecht, K; Vince, GH; Vordermark, D; Warmuth-Metz, M1
Glas, M; Herrlinger, U; Hundsberger, T; Kurzwelly, D; Nguyen-Huu, B; Rasch, K; Stuplich, M; Wiewrodt, D1
Bertalanffy, H; Bozinov, O; Kalk, JM; Krayenbühl, N; Sure, U; Woernle, CM1
Chen, ZP; Jiang, XB; Mu, YG; Sai, K; Shen, D; Yang, QY; Zhang, XH1
Atta, J; Franz, K; Lemercier, S; Rieger, J; Steinbach, JP; Sulzbacher, A; Thiepold, AL1

Reviews

1 review(s) available for arginine and nimustine

ArticleYear
[Standards and new developments in the chemotherapy of glioblastomas].
    Deutsche medizinische Wochenschrift (1946), 2005, Oct-07, Volume: 130, Issue:40

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cytarabine; Dacarbazine; Decanoic Acids; DNA Modification Methylases; Glioblastoma; Humans; Nimustine; Polyesters; Promoter Regions, Genetic; Temozolomide; Teniposide

2005

Trials

1 trial(s) available for arginine and nimustine

ArticleYear
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-01, Volume: 21, Issue:17

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nimustine; Prognosis; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome

2003

Other Studies

15 other study(ies) available for arginine and nimustine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
[Chemotherapy in malignant gliomas].
    Neurochirurgia, 1990, Volume: 33 Suppl 1

    Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cytarabine; Follow-Up Studies; Glioma; Humans; Nimustine; Survival Rate; Teniposide

1990
[Second-look operations and chemotherapy for malignant tumors of the brain].
    Gan no rinsho. Japan journal of cancer clinics, 1983, Volume: 29, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Reoperation; Teniposide

1983
[Synchronization chemoradiotherapy for malignant gliomas].
    No shinkei geka. Neurological surgery, 1984, Volume: 12, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Glioma; Humans; Nimustine; Nitrosourea Compounds; Teniposide; Vincristine

1984
Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?
    Neurology, 1997, Volume: 48, Issue:6

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Cell Cycle; Cell Survival; Cytarabine; Dexamethasone; Doxorubicin; Drug Interactions; Glioma; Humans; Methotrexate; Nimustine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Teniposide; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine

1997
Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy.
    Acta neuropathologica, 1997, Volume: 94, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Drug Resistance, Neoplasm; Glioblastoma; Glutathione Transferase; Humans; Immunohistochemistry; Isoenzymes; Karnofsky Performance Status; Nimustine; Teniposide

1997
CD95-mediated apoptosis: no variation in cellular sensitivity during cell cycle progression.
    FEBS letters, 1998, Aug-07, Volume: 432, Issue:3

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Aphidicolin; Apoptosis; Camptothecin; Cell Cycle; Cell Death; Cisplatin; Culture Media, Serum-Free; Doxorubicin; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Gene Expression; HeLa Cells; Humans; Hydroxyurea; Jurkat Cells; Membrane Glycoproteins; Nimustine; Nocodazole; Paclitaxel; Sensitivity and Specificity; Teniposide; Tumor Cells, Cultured; Vincristine

1998
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
    Journal of neuro-oncology, 2000, Volume: 48, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53

2000
[Glioblastoma multiforme of the optic nerve].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:11

    Topics: Antineoplastic Agents; Contrast Media; Diagnosis, Differential; Follow-Up Studies; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nimustine; Optic Nerve; Optic Nerve Neoplasms; Teniposide; Time Factors

2004
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    BMC cancer, 2005, May-30, Volume: 5

    Topics: Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Nimustine; Prognosis; Radiosurgery; Radiotherapy; Recurrence; Stereotaxic Techniques; Teniposide; Time Factors; Treatment Outcome

2005
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    BMC cancer, 2006, Oct-18, Volume: 6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Craniotomy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Life Tables; Male; Middle Aged; Nimustine; Oligodendroglia; Oligodendroglioma; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Treatment Outcome

2006
Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
    Oncology, 2009, Volume: 76, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Retrospective Studies; Teniposide

2009
Decreasing expression of the interleukin-13 receptor IL-13Ralpha2 in treated recurrent malignant gliomas.
    Neurologia medico-chirurgica, 2010, Volume: 50, Issue:8

    Topics: Actins; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Exotoxins; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Immunotoxins; Interleukin-13; Interleukin-13 Receptor alpha2 Subunit; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Recombinant Fusion Proteins; RNA; Teniposide; Young Adult

2010
[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Child; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Nausea; Neutropenia; Nimustine; Temozolomide; Teniposide; Thrombocytopenia; Young Adult

2011
Prophylactic use of pegfilgrastim in patients treated with a nitrosourea and teniposide for recurrent glioma.
    Pharmacotherapy, 2014, Volume: 34, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Communicable Diseases; Disease-Free Survival; Female; Filgrastim; Germany; Glioma; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Severity of Illness Index; Survival Rate; Teniposide

2014